135 related articles for article (PubMed ID: 22442112)
21. Characterization of the chromosomal binding sites and dimerization partners of the viral oncoprotein Meq in Marek's disease virus-transformed T cells.
Levy AM; Izumiya Y; Brunovskis P; Xia L; Parcells MS; Reddy SM; Lee L; Chen HW; Kung HJ
J Virol; 2003 Dec; 77(23):12841-51. PubMed ID: 14610205
[TBL] [Abstract][Full Text] [Related]
22. Multiple alternative splicing to exons II and III of viral interleukin-8 (vIL-8) in the Marek's disease virus genome: the importance of vIL-8 exon I.
Jarosinski KW; Schat KA
Virus Genes; 2007 Jan; 34(1):9-22. PubMed ID: 16927116
[TBL] [Abstract][Full Text] [Related]
23. Marek's disease: Genetic regulation of gallid herpesvirus 2 infection and latency.
Gennart I; Coupeau D; Pejaković S; Laurent S; Rasschaert D; Muylkens B
Vet J; 2015 Sep; 205(3):339-48. PubMed ID: 26067852
[TBL] [Abstract][Full Text] [Related]
24. Identification and characterization of Marek's disease virus serotype 1 (MDV1) ICP22 gene product: MDV1 ICP22 transactivates the MDV1 ICP27 promoter synergistically with MDV1 ICP4.
Kato K; Izumiya Y; Tohya Y; Takahashi E; Hirai K; Kawaguchi Y
Vet Microbiol; 2002 Apr; 85(4):305-13. PubMed ID: 11856580
[TBL] [Abstract][Full Text] [Related]
25. Differential attenuation of Marek's disease virus-induced tumours and late-Marek's disease virus-induced immunosuppression.
Faiz NM; Cortes AL; Guy JS; Reddy SM; Gimeno IM
J Gen Virol; 2018 Jul; 99(7):927-936. PubMed ID: 29767614
[TBL] [Abstract][Full Text] [Related]
26. Roles of avian herpesvirus microRNAs in infection, latency, and oncogenesis.
Morgan RW; Burnside J
Biochim Biophys Acta; 2011; 1809(11-12):654-9. PubMed ID: 21683170
[TBL] [Abstract][Full Text] [Related]
27. MiRNA expression signatures induced by Marek's disease virus infection in chickens.
Tian F; Luo J; Zhang H; Chang S; Song J
Genomics; 2012 Mar; 99(3):152-9. PubMed ID: 22178800
[TBL] [Abstract][Full Text] [Related]
28. Sequence conservation and differential expression of Marek's disease virus microRNAs.
Morgan R; Anderson A; Bernberg E; Kamboj S; Huang E; Lagasse G; Isaacs G; Parcells M; Meyers BC; Green PJ; Burnside J
J Virol; 2008 Dec; 82(24):12213-20. PubMed ID: 18842708
[TBL] [Abstract][Full Text] [Related]
29. Oncogenic Marek's disease herpesvirus encodes an isoform of the conserved regulatory immediate early protein ICP27 generated by alternative promoter usage.
Strassheim S; Gennart I; Muylkens B; André M; Rasschaert D; Laurent S
J Gen Virol; 2016 Sep; 97(9):2399-2410. PubMed ID: 27411695
[TBL] [Abstract][Full Text] [Related]
30. Identification and characterization of a novel spliced form of the meq transcript in lymphoblastoid cell lines derived from Marek's disease tumours.
Okada T; Takagi M; Murata S; Onuma M; Ohashi K
J Gen Virol; 2007 Aug; 88(Pt 8):2111-2120. PubMed ID: 17622612
[TBL] [Abstract][Full Text] [Related]
31. Marek's disease virus reactivation from latency: changes in gene expression at the origin of replication.
Parcells MS; Arumugaswami V; Prigge JT; Pandya K; Dienglewicz RL
Poult Sci; 2003 Jun; 82(6):893-8. PubMed ID: 12817443
[TBL] [Abstract][Full Text] [Related]
32. Suppression of transcription activity of the MEQ protein of oncogenic Marek's disease virus serotype 1 (MDV1) by L-MEQ of non-oncogenic MDV1.
Chang KS; Ohashi K; Onuma M
J Vet Med Sci; 2002 Dec; 64(12):1091-5. PubMed ID: 12520099
[TBL] [Abstract][Full Text] [Related]
33. In vitro characterization of the Meq proteins of Marek's disease virus vaccine strain CVI988.
Ajithdoss DK; Reddy SM; Suchodolski PF; Lee LF; Kung HJ; Lupiani B
Virus Res; 2009 Jun; 142(1-2):57-67. PubMed ID: 19189855
[TBL] [Abstract][Full Text] [Related]
34. Emerging roles of chicken and viral microRNAs in avian disease.
Burnside J; Morgan R
BMC Proc; 2011 Jun; 5 Suppl 4(Suppl 4):S2. PubMed ID: 21645299
[TBL] [Abstract][Full Text] [Related]
35. Selection of a recombinant Marek's disease virus in vivo through expression of the Marek's EcoRI-Q (Meq)-encoded oncoprotein: characterization of an rMd5-based mutant expressing the Meq of strain RB-1B.
Kumar P; Dong H; Lenihan D; Gaddamanugu S; Katneni U; Shaikh S; Tavlarides-Hontz P; Reddy SM; Peters W; Parcells MS
Avian Dis; 2012 Jun; 56(2):328-40. PubMed ID: 22856190
[TBL] [Abstract][Full Text] [Related]
36. Construction of recombinant Marek's disease virus (MDV) lacking the meq oncogene and co-expressing AIV-H9N2 HA and NA genes under control of exogenous promoters.
Zhang Z; Chen W; Ma C; Zhao P; Duan L; Zhang F; Sun A; Li Y; Su H; Li S; Cui H; Cui Z
J Biotechnol; 2014 Jul; 181():45-54. PubMed ID: 24709399
[TBL] [Abstract][Full Text] [Related]
37. Expression profiles of microRNAs encoded by the oncogenic Marek's disease virus reveal two distinct expression patterns in vivo during different phases of disease.
Luo J; Sun AJ; Teng M; Zhou H; Cui ZZ; Qu LH; Zhang GP
J Gen Virol; 2011 Mar; 92(Pt 3):608-20. PubMed ID: 21148277
[TBL] [Abstract][Full Text] [Related]
38. Expression of Marek's Disease Virus Oncoprotein Meq During Infection in the Natural Host.
Tai SS; Hearn C; Umthong S; Agafitei O; Cheng HH; Dunn JR; Niikura M
Virology; 2017 Mar; 503():103-113. PubMed ID: 28160668
[TBL] [Abstract][Full Text] [Related]
39. The interplay between MDV and HVT affects viral miRNa expression.
Goher M; Hicks JA; Liu HC
Avian Dis; 2013 Jun; 57(2 Suppl):372-9. PubMed ID: 23901749
[TBL] [Abstract][Full Text] [Related]
40. Diversity (polymorphism) of the meq gene in the attenuated Marek's disease virus (MDV) serotype 1 and MDV-transformed cell lines.
Chang KS; Ohashi K; Onuma M
J Vet Med Sci; 2002 Dec; 64(12):1097-101. PubMed ID: 12520100
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
